Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements Of Cash Flows Unaudited

 v2.3.0.11
Condensed Statements Of Cash Flows Unaudited (USD $)
9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Net income $ 2,311,475 $ 360,962
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 266,419 363,192
Deferred taxes 61,605 63,316
Gain on disposal of assets (44,352)  
Stock based compensation 208,557 119,106
Changes in operating assets and liabilities:    
Accounts receivable, net (394,606) 249,529
Inventories (685,263) (277,930)
Prepaid expenses and other (125,338) (76,068)
Accounts payable and accrued expenses 1,471,856 (544,371)
Net cash provided by operating activities 3,070,353 257,736
Cash flows from investing activities    
Purchases of property and equipment (577,919) (343,035)
Proceeds from sale of assets 660,292  
Patent additions   (27,649)
Purchases of investments (1,395,659) (2,008,163)
Proceeds from maturities of investments 1,039,690 1,851,000
Proceeds from notes receivable   435,336
Net cash used in investing activities (273,596) (92,511)
Cash flows from financing activities    
Repayment of long-term debt   (33,081)
Proceeds from issuance of common stock under employee stock purchase plan 87,667  
Proceeds from issuance of common stock upon exercise of stock options 58,944 22,437
Net cash provided by (used in) financing activities 146,611 (10,644)
Increase in cash and cash equivalents 2,943,368 154,581
Cash and cash equivalents, beginning of period 5,285,719 4,731,735
Cash and cash equivalents, end of period $ 8,229,087 $ 4,886,316